ResearcherChang Gung UniversityNo recent work listed
Horng‐Heng Juang
Matched on ORCID iD 0000-0002-8524-8253; OpenAlex author ID A5052821023. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2013: 1 paper · 2014: 1 paper
Papers 2
- The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial-mesenchymal transition in pancreatic cancer cells. Last author DOI 10.1016/j.canlet.2014.08.019↗
- Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo. Co-author DOI 10.4161/cc.24445↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tai C. Chen · 2 shared papers, 2013–2014 · strength 0.07
- Paper The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial-mesenchymal transition i… DOI 10.1016/j.canlet.2014.08.019↗
- Paper Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic canc… DOI 10.4161/cc.24445↗
- Chun‐Nan Yeh · 2 shared papers, 2013–2014 · strength 0.07
- Paper The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial-mesenchymal transition i… DOI 10.1016/j.canlet.2014.08.019↗
- Paper Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic canc… DOI 10.4161/cc.24445↗
- Kun‐Chun Chiang · 2 shared papers, 2013–2014 · strength 0.07
- Paper The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial-mesenchymal transition i… DOI 10.1016/j.canlet.2014.08.019↗
- Paper Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic canc… DOI 10.4161/cc.24445↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.